- Home
- INDP vs SPHL Comparison
INDP vs SPHL Comparison
Compare INDP & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- SPHL
- Stock Information
- Founded
- INDP 2000
- SPHL 2002
- Country
- INDP United States
- SPHL Singapore
- Employees
- INDP N/A
- SPHL N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- SPHL Homebuilding
- Sector
- INDP Health Care
- SPHL Consumer Discretionary
- Exchange
- INDP Nasdaq
- SPHL Nasdaq
- Market Cap
- INDP 8.8M
- SPHL 7.3M
- IPO Year
- INDP N/A
- SPHL 2024
- Fundamental
- Price
- INDP $0.59
- SPHL $0.55
- Analyst Decision
- INDP Strong Buy
- SPHL
- Analyst Count
- INDP 2
- SPHL 0
- Target Price
- INDP $8.50
- SPHL N/A
- AVG Volume (30 Days)
- INDP 1.2M
- SPHL 1.6M
- Earning Date
- INDP 03-13-2025
- SPHL 02-21-2025
- Dividend Yield
- INDP N/A
- SPHL N/A
- EPS Growth
- INDP N/A
- SPHL 413.11
- EPS
- INDP N/A
- SPHL 0.09
- Revenue
- INDP N/A
- SPHL $11,020,429.00
- Revenue This Year
- INDP N/A
- SPHL N/A
- Revenue Next Year
- INDP N/A
- SPHL N/A
- P/E Ratio
- INDP N/A
- SPHL $6.30
- Revenue Growth
- INDP N/A
- SPHL 112.84
- 52 Week Low
- INDP $0.58
- SPHL $0.51
- 52 Week High
- INDP $3.10
- SPHL $7.80
- Technical
- Relative Strength Index (RSI)
- INDP 30.03
- SPHL N/A
- Support Level
- INDP $0.58
- SPHL N/A
- Resistance Level
- INDP $0.78
- SPHL N/A
- Average True Range (ATR)
- INDP 0.14
- SPHL 0.00
- MACD
- INDP -0.02
- SPHL 0.00
- Stochastic Oscillator
- INDP 0.89
- SPHL 0.00
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.